277 related articles for article (PubMed ID: 26012253)
41. Chiral Inhibition of Rivaroxaban Derivatives Towards UDP-Glucuronosyltransferase (UGT) Isoforms.
Yao Z; Liu YZ; Ma AL; Wang SF; Lu D; Hu CM; Zhang YY; Wang H; Hu L; Deng J; Yang K; Fang ZZ
Chirality; 2015 Dec; 27(12):936-43. PubMed ID: 26425918
[TBL] [Abstract][Full Text] [Related]
42. In vitro assay of six UDP-glucuronosyltransferase isoforms in human liver microsomes, using cocktails of probe substrates and liquid chromatography-tandem mass spectrometry.
Seo KA; Kim HJ; Jeong ES; Abdalla N; Choi CS; Kim DH; Shin JG
Drug Metab Dispos; 2014 Nov; 42(11):1803-10. PubMed ID: 25122565
[TBL] [Abstract][Full Text] [Related]
43. Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.
Ramírez J; Mirkov S; House LK; Ratain MJ
Drug Metab Dispos; 2015 Jul; 43(7):928-35. PubMed ID: 25870101
[TBL] [Abstract][Full Text] [Related]
44. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
[TBL] [Abstract][Full Text] [Related]
45. In vitro evidence for bakuchiol's influence towards drug metabolism through inhibition of UDP-glucuronosyltransferase (UGT) 2B7.
Xu Y; Li P; Zhang X; Wang J; Gu D; Wang Y
Afr Health Sci; 2014 Sep; 14(3):564-9. PubMed ID: 25352873
[TBL] [Abstract][Full Text] [Related]
46. Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases.
Lv X; Zhang JB; Wang XX; Hu WZ; Shi YS; Liu SW; Hao DC; Zhang WD; Ge GB; Hou J; Yang L
Chem Biol Interact; 2018 Mar; 284():48-55. PubMed ID: 29470958
[TBL] [Abstract][Full Text] [Related]
47. Everolimus-inhibited multiple isoforms of UDP-glucuronosyltransferases (UGTs).
Du Z; Wang G; Cao YF; Hu CM; Yang K; Liu YZ; Zhang CZ; Zhang WH; Zhu ZT; Sun HZ; Sun XY; Hong M; Fang ZZ
Xenobiotica; 2018 May; 48(5):452-458. PubMed ID: 28548030
[TBL] [Abstract][Full Text] [Related]
48. Per- and polyfluoroalkyl substances display structure-dependent inhibition towards UDP-glucuronosyltransferases.
Liu YZ; Zhang ZP; Fu ZW; Yang K; Ding N; Hu LG; Fang ZZ; Zhuo X
Environ Pollut; 2019 Nov; 254(Pt B):113093. PubMed ID: 31472452
[TBL] [Abstract][Full Text] [Related]
49. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261
[TBL] [Abstract][Full Text] [Related]
50. The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Nov; 35(11):2040-4. PubMed ID: 17670842
[TBL] [Abstract][Full Text] [Related]
51. Glucuronidation of macelignan by human liver microsomes and expressed UGT enzymes: identification of UGT1A1 and 2B7 as the main contributing enzymes.
Liu H; Wu Z; Ma Z; Wu B
Biopharm Drug Dispos; 2014 Dec; 35(9):513-24. PubMed ID: 25099990
[TBL] [Abstract][Full Text] [Related]
52. Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms.
Lee H; Heo JK; Lee GH; Park SY; Jang SN; Kim HJ; Kwon MJ; Song IS; Liu KH
Drug Metab Dispos; 2019 Dec; 47(12):1372-1379. PubMed ID: 31578207
[TBL] [Abstract][Full Text] [Related]
53. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory effects of tanshinones towards the catalytic activity of UDP-glucuronosyltransferases (UGTs).
Zhang XX; Cao YF; Wang LX; Yuan XL; Fang ZZ
Pharm Biol; 2017 Dec; 55(1):1703-1709. PubMed ID: 28466663
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia.
Miners JO; Chau N; Rowland A; Burns K; McKinnon RA; Mackenzie PI; Tucker GT; Knights KM; Kichenadasse G
Biochem Pharmacol; 2017 Apr; 129():85-95. PubMed ID: 28065859
[TBL] [Abstract][Full Text] [Related]
56. Design and optimization of the cocktail assay for rapid assessment of the activity of UGT enzymes in human and rat liver microsomes.
Chen A; Zhou X; Cheng Y; Tang S; Liu M; Wang X
Toxicol Lett; 2018 Oct; 295():379-389. PubMed ID: 30036684
[TBL] [Abstract][Full Text] [Related]
57. Identification and characterization of in vitro inhibitors against UDP-glucuronosyltransferase 1A1 in uva-ursi extracts and evaluation of in vivo uva-ursi-drug interactions.
Park JB; Kim D; Min JS; Jeong S; Cho DY; Zheng YF; Yoon KD; Bae SK
Food Chem Toxicol; 2018 Oct; 120():651-661. PubMed ID: 30075316
[TBL] [Abstract][Full Text] [Related]
58. Comparison of inhibition capability of scutellarein and scutellarin towards important liver UDP-glucuronosyltransferase (UGT) isoforms.
Ma GY; Cao YF; Hu CM; Fang ZZ; Sun XY; Hong M; Zhu ZT
Phytother Res; 2014 Mar; 28(3):382-6. PubMed ID: 23620377
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of UDP-glucuronosyltransferase (UGT)-mediated glycyrrhetinic acid 3-O-glucuronidation by polyphenols and triterpenoids.
Koyama M; Shirahata T; Hirashima R; Kobayashi Y; Itoh T; Fujiwara R
Drug Metab Pharmacokinet; 2017 Aug; 32(4):218-223. PubMed ID: 28754329
[TBL] [Abstract][Full Text] [Related]
60. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.
Aprile S; Del Grosso E; Grosa G
Drug Metab Dispos; 2010 Jul; 38(7):1141-6. PubMed ID: 20375181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]